Particularly in brain and breast cancer patients, loss of PTEN function has been related to metastasis and a lack of response to radiotherapy and chemotherapy, demonstrating that PTEN is a critical regulator of tumor susceptibility to several treatment options [83,84,85]. This evidence concerns the gene PTEN and breast carcinoma.